Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-22-046488

SVP & General Counsel sold 3,189 shares at $4.76 ($15,180)

  • SVP & General Counsel acquired 165,938 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Wilson Mark Andrew SVP & General Counsel 2022-08-15 Grant or award +165,938 284,377 D
Wilson Mark Andrew SVP & General Counsel 2022-08-16 Sale −3,189 $4.76 $15,180 281,188 D
Derivatives
Wilson Mark Andrew SVP & General Counsel 2022-08-15 Grant or award · Common Stock +331,875 331,875 D
Open-market sales · 3,189 sh · avg $4.76 · $15,180
Loading xslF345X03/doc4.xml…